molybdenum has been researched along with Neoplasms in 108 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 11 (10.19) | 18.7374 |
1990's | 3 (2.78) | 18.2507 |
2000's | 20 (18.52) | 29.6817 |
2010's | 39 (36.11) | 24.3611 |
2020's | 35 (32.41) | 2.80 |
Authors | Studies |
---|---|
Du, L; Gao, F; Jiang, Y; Li, H; Li, J; Sun, Z; Tong, Y; Wang, C; Zhao, L | 1 |
Guo, Y; Shi, J; Yang, B; Yang, J; Yao, H | 1 |
Li, J; Lu, C; Xie, M; Yang, M; Yang, N | 1 |
Li, J; Li, Z; Wang, S; Wu, H; Zhang, J; Zhang, L; Zhang, Y; Zhao, J; Zhao, Y; Zou, D | 1 |
Chen, H; Guo, Y; Guo, Z; Lan, P; Li, M; Li, Y; Liu, Z; Zhang, Y; Zheng, Y | 1 |
Ma, X; Qi, Y; Qian, Z; Song, Y; Yuan, W; Yuan, Y | 1 |
Cao, G; Gao, D; He, Y; Ma, Z; Ni, S; Tang, Y; Wang, D; Wang, J; Xu, Z; Yuan, Y | 1 |
Cai, HL; Lv, Z; Song, R; Song, X; Tang, W; Wang, Y; Wei, J; Wu, XS; Wu, Y; Yang, D; Zhang, A; Zhong, W; Zhou, X | 1 |
Cheng, L; Cheng, S; Gong, F; Han, Z; Lei, H; Liu, Z; Wang, L; Wang, T; Wang, Y; Yang, N; Yang, X; Zhou, Y | 1 |
Deshpande, UP; Kakati, M; Murty, US; Pemmaraju, DB; Phukan, S; Rahman, M; Sathe, V | 1 |
Liu, J; Smith, S; Wang, C | 1 |
Chen, J; Chen, Y; Feng, W; Xia, L; Xia, W; Xie, Y; Zhang, S | 1 |
Guo, J; Huang, Z; Liu, H; Pan, X; Shi, R; Wu, Q; Xue, Y; Zhang, H; Zhang, J | 1 |
Deng, L; Li, Y; Liu, H; Wang, K; Wang, L; Yan, J; Zhang, G | 1 |
Dolati, A; Karimi, M; Kiani, J; Madjd, Z; Naseri, N; Ranjbar, S; Saeedi, S; Vojgani, Y | 1 |
Bai, Q; Lin, H; Liu, J; Qu, F; Sun, X; Wang, M; Yang, P | 1 |
Cheng, L; Huang, Y; Lai, Z; Liu, T; Liu, Z; Shen, S; Tran, TH; Zhang, X | 1 |
Liu, X; Qu, X; Ren, J; Wu, S | 1 |
Cheng, J; Deng, T; Feng, C; Li, Y; Xie, M; Yang, M; Yang, N | 1 |
Cai, L; Dong, L; Li, J; Wang, Q; Wang, Y; Xu, K; Zhao, M | 1 |
Annušová, A; Benkovičová, M; Bodík, M; Jergel, M; Kálosi, A; Kasak, P; Kollár, J; Kotlár, M; Labudová, M; Majkova, E; Pastoreková, S; Siffalovic, P | 1 |
Han, Y; Li, J; Li, W; Peng, X; Qu, B; Zhang, R; Zhang, X | 1 |
Cai, L; Chen, M; Dong, L; Li, J; Lu, J; Wang, Q; Zhao, M | 1 |
Cheng, J; Li, J; Shi, J; Wang, Y; Zhang, CY | 1 |
Rieber, M | 1 |
Chen, Y; Li, J; Liu, X; Liu, Y; Wang, S; Zhang, J; Zhao, J; Zheng, Y; Zhou, L | 1 |
Aasen, T; Abdul Moin, NI; Abdul Wafi, S; Aboukameel, A; Abu-Bakar, N; Acharya, A; Ackermans, L; Adaramoye, O; Adarsh, KV; Adeosun, WA; Ahmad, NH; Ahmadi, F; Akanni, O; Akbar, M; Akbulak, RO; Akev, N; Akkaya, Ö; Al-Rashed, S; AlAbbad, S; Alabi, O; Alappat, BJ; Alcalá, S; Alcoutlabi, M; Aleppo, G; Alexander Ross, JB; Alexander, JH; Alexander, R; Alias, A; Alimba, C; Alken, FA; Allan, R; Alpers, M; Alsbou, EM; Amarasiri, SS; An, T; Anastasiadis, F; Anastassiadou, M; Anderson, KC; Andronikos, P; Anheyer, D; Annapurna, K; Anorlu, RI; Anten, MM; Anthopoulos, TD; Araujo-Castillo, RV; Aravamudhan, S; Arawwawala, LDAM; Arulsamy, N; Arunamata, A; Asghar, A; Asiri, AM; Aslanidou, T; Astrakhantseva, IV; Astutik, E; Attanayake, AP; Atwater, BD; Audureau, E; Augusto, S; Bakare, A; Banach, M; Bandelier, P; Banerjee, S; Barral, M; Bascuñán, J; Bates, FS; Bauer, NJC; Bayrak, BB; Beck, RW; Beckervordersantforth, J; Beeri, R; Begum, R; Beldi-Ferchiou, A; Bellingham, G; Ben-Tal, N; Bendib, I; Bergenstal, RM; Berger, MF; Bernasconi, G; Berry, S; Beuvon, F; Bi, WJ; Bi, Z; Bianconi, V; Bibi, I; Blank, BR; Bliemeister, E; Bobkowski, W; Bode, AM; Booth, CM; Bose, U; Boyd, K; Brancato, A; Brenmoehl, J; Brogi, E; Bronzo, P; Brooks, T; Brown, D; Brown, DN; Bruce, D; Buan, MEM; Bueno-Hernández, F; Bugielski, B; Bulavaitė, A; Buscagan, TM; Buxton, R; Caffaro, MM; Cai, Q; Cai, X; Cai, Y; Calhoun, P; Callander, N; Cambier, S; Camparo, P; Canales-Vargas, EJ; Canham, K; Cantu, J; Cao, J; Cao, JW; Cao, P; Cao, T; Cao, X; Caravella, BA; Carcadea, E; Carè, J; Carmichael, P; Carrasco Cabrera, L; Carteaux, G; Carvalho, PDS; Casarez, E; Cazorla, M; Celestrin, CP; Chakraborty, NK; Chan, B; Chandarlapaty, S; Chandgude, AL; Chang, CC; Chang, JH; Chang, X; Chang, Y; Chankhanittha, T; Chantanis, S; Chapovetsky, A; Chavan, S; Chen, B; Chen, D; Chen, F; Chen, G; Chen, H; Chen, J; Chen, K; Chen, KJ; Chen, KP; Chen, L; Chen, MA; Chen, Q; Chen, S; Chen, W; Chen, WF; Chen, X; Chen, Y; Cheng, D; Cheng, J; Cheng, Q; Cheon, GJ; Chiu, SC; Cho, CH; Cho, J; Choi, H; Choi, JS; Choi, YH; Christie, P; Chu, CH; Chu, Y; Chung, DH; Chung, F; Cline, JP; Cohen, A; Cohen, AD; Cohen, NJ; Comen, E; Compter, I; Cong, J; Cong, Z; Cooper, A; Cornud, F; Costa, C; Costa, S; Covey, A; Cowan, AM; Cramer, H; Cruz-Rivera, C; Cui, J; Cui, M; Cui, Y; Cui, YH; Culquichicón, C; Cushman, T; D'Auria, SJ; da Silva, J; Dalgediene, I; Danenberg, HD; Das, S; Dasgupta, K; Daubit, IM; de Oliveira, PD; de Prost, N; De Ruysscher, D; Dearman, K; Decato, D; Delfau-Larue, MH; Deng, L; Dhakate, SR; Dharuman, V; Di Costanzo, N; Dickler, MN; Dinehart, EE; Ding, D; Dinh, TK; Divya, KP; Djifack Tadongfack, T; Do, T; Domínguez-Roldan, R; Domínguez-Zambrano, E; Dömling, A; Donato, MD; Dong, JH; Dong, W; Dong, X; Dong, XR; Dong, Y; Dong, Z; Downs, M; Drutskaya, MS; Du, B; Du, F; Du, H; Du, L; Du, X; Duan, Z; Duangthip, D; Dunstand-Guzmán, E; Duong, F; Eckert, DJ; Edelhäuser, BAH; Eekers, DBP; Efendi, F; Efraimidis, P; Ehrenberg, H; Ehsanbakhsh, Z; Eickholt, C; Eksterowicz, J; El Mobadder, M; El-Araby, IE; El-Magd, MA; El-Tarabany, MS; Elgorban, AM; Engelmann, D; English, KL; Esfandiari, H; Eslami, B; Espinosa-Cuevas, A; Eswara, S; Faber, E; Fan, XH; Fan, Y; Fang, J; Fang, Z; Fantin, VR; Fei, P; Feng, G; Feng, H; Feng, J; Feng, X; Feng, XJ; Fennell, TR; Fernández-Moreira, V; Ferraz, ABF; Ferreras, KN; Flores, K; Flores-Pérez, I; Flox, C; Fluharty, FL; Fokouong Tchoffo, E; Folefack, GO; Foroutan, T; Fort, D; Fourati, S; Fousas, S; Frapard, T; Freguia, S; Friedman, DJ; Friedman, LS; Fu, D; Fu, Q; Fu, Y; Fujinami, S; Furihata, K; Gal, RL; Gan, H; Gao, C; Gao, F; Gao, R; Gao, SS; Gao, W; Gao, XC; Gao, Y; Gao, Z; Garozi, L; Ge, J; Georgiopoulos, A; Gerakiou, K; Ghazimirsaeed, SM; Ghazimirsaeed, ST; Gimeno, MC; Gjestad, R; Glurich, I; Goetchius, E; Goland, S; Goldstein, S; Gonçalves, CM; Gonçalves, H; Gong, Q; Gonzalez, D; Goplen, FK; Gorshkova, EN; Gotsman, I; Govindasamy, V; Granger, CB; Greco, L; Grigoriadou-Skouta, E; Grigoropoulos, P; Grivicich, I; Gromov, NV; Gruber, S; Grytczuk, M; Grzech-Leśniak, K; Gu, L; Gu, S; Gu, Z; Guadagnini, D; Guan, H; Guilliams, M; Guo, J; Guo, L; Gupta, A; Gupta, SK; Gurzu, S; Gutleb, AC; Haban, A; Hablitz, JJ; Hadisuyatmana, S; Hahn, S; Haiges, R; Hallal-Calleros, C; Hamed, M; Hammad, N; Hammer, N; Han, C; Hao, Y; Harnett, J; Has, EMM; Hassanpour, K; Hatzopoulos, D; Hawaldar, R; He, X; He, Y; He, YY; He, Z; Heberman, D; Heckl, D; Hegde, H; Henson, MA; Hernández-Velázquez, VM; Herrera, E; Hijazi, Z; Hirayama, K; Hirth, JM; Hoeben, A; Hohnloser, SH; Hong, M; Hood, K; Hoplock, LB; Hopman, WM; Horlbogen, LM; Hossein Rashidi, B; Hou, G; Hou, H; Hou, J; Hou, Y; Hu, J; Hu, W; Hu, X; Hua, W; Huang, G; Huang, H; Huang, J; Huang, T; Huang, W; Huang, Y; Huang, YD; Huang, Z; Hudis, CA; Hue, S; Huo, J; Hussain, M; Hvas, AM; Ichii, T; Ide Zeuna, J; Ilyas, S; Inoue, T; Iranzo, A; Irfan, M; Iwasa, Y; Iwashita, Y; Izgorodina, EI; J R, A; Jaber, WA; Jaborek, JR; Jacobus, SJ; Jadeja, SD; Jafarabadi, M; Jalan, D; Jamil, MI; Jarrah, S; Jarvis, D; Jayatilaka, KAPW; Jemal-Turki, A; Jeon, YK; Jeong, N; Jeong, SH; Jeong, SY; Jermy, M; Jhaveri, K; Ji, H; Ji, K; Ji, RY; Jiang, F; Jiang, J; Jiang, X; Jiang, Y; Jiao, Q; Jilani, K; Jiménez-Guerrero, P; Jin, L; Jo, YH; Johnson, JG; Johnson, ML; Jones, WS; Jose, S; Jularic, M; Jung, I; Jung, YJ; Jungen, C; Junttila, MR; Kache, S; Kahanovitch, U; Kalantzi, KI; Kallio, T; Kamnoedboon, P; Kang, CH; Kang, H; Kang, J; Kang, KW; Kapoor, P; Karmakar, D; Kartalis, A; Kauranen, P; Kazocina, A; Keikha, F; Keltai, M; Kershaw, SV; Kettani, M; Khalvati, S; Khandhar, S; Khosla, N; Kiely, CJ; Kim, CC; Kim, H; Kim, MJ; Kim, Y; Kim, YH; Kim, YT; Kimoto, E; Kiyu, A; Klatt, N; Kobayashi, M; Koh, J; Köhler, R; Kondadasula, SV; Kong, H; Kong, W; Kong, X; Kotidis, A; Kotwal, A; Kouvari, M; Kozhinov, AN; Kruger, D; Kuang, S; Kuang, Y; Kubota, M; Kuklik, P; Kumar, P; Kumar, SK; Kuo, YF; Kurup, SP; Kusuhara, H; Kuswanto, H; Lacouture, ME; Lambin, P; Lang, CC; Langroudi, FH; Lanman, RB; Larsen, OH; Laskin, J; Le, VH; Leach, M; Lee, BG; Lee, DF; Lee, DS; Lee, HJ; Lee, SB; Lee, YA; Lei, Y; Lekashvili, O; Lelj, F; Lemin, AS; Lemoine, J; Leuschner, R; Li, B; Li, BT; Li, C; Li, D; Li, F; Li, G; Li, H; Li, HW; Li, J; Li, M; Li, P; Li, Q; Li, S; Li, W; Li, X; Li, XY; Li, Y; Li, Z; Lian, Y; Liang, C; Liao, J; Liao, W; Liao, Y; Lin, D; Lin, W; Lin, YL; Lindbäck, J; Lindsay, AP; Ling, J; Linser, PJ; Liu, C; Liu, H; Liu, JJ; Liu, L; Liu, Q; Liu, SF; Liu, X; Liu, Y; Liu, Z; Liu, ZM; Lo Sterzo, C; Lo, ECM; Lobchuk, MM; Lodge, TP; Logotheti, S; Lonial, S; Lopes, G; Lopes, RD; Lopez, J; Lopez, SA; López-Santos, AL; López-Sendón, JL; Loring, Z; Louis, C; Lovita, AND; Lu, DZ; Lu, H; Lu, J; Lu, K; Lu, TT; Lu, Y; Luengo, A; Lum, LG; Luna, JM; Luo, L; Luo, R; Luo, T; Luo, X; Luo, Z; Lv, B; Lymperopoulos, N; Lyras, A; Lyu, Y; M Kannan, A; Ma, H; Ma, M; Ma, Q; Ma, S; Ma, WY; Ma, Y; Maalouf, E; Machado, FA; Maeda, K; Magrans, JO; Maharani, A; Maia, G; Mainwaring, RD; Maji, TK; Majumdar, K; Mannarino, MR; Mansuri, MS; Marinescu, SC; Markatos, G; Marquardt, S; Marraiki, N; Martens, C; Martínez, TJ; Marumo, K; Maruyama, H; Marwani, HM; Marzo, I; Masrati, G; Matamba, P; Mathialagan, S; Matys, J; Mayatra, JM; Mboua, PC; McArthur, T; McCrimmon, RJ; McIntosh, S; McSpadden, S; Medina-Campos, ON; Medvedovsky, AT; Mei, Z; Mekontso-Dessap, A; Menezes, AMB; Meng, J; Meng, P; Meng, Y; Menter, A; Mets, MB; Mets-Halgrimson, R; Metzger, T; Metzler-Nolte, N; Meyer, C; Mi, Y; Michailoviene, V; Mikrogeorgiou, A; Militz, H; Miller Iii, TF; Minarowska, A; Mir, S; Miron, I; Miyake, T; Moayer, F; Modi, S; Moeller, SJ; Mohamad, MN; Mohammed, EHM; Mokhonov, VV; Mondal, A; Moore, J; Moravcova, M; Mordi, IR; Mordi, NA; Mortensen, NP; Moscariello, C; Moser, J; Moynahan, ME; Mu, J; Mu, W; Mudduwa, LKB; Mukherjee, S; Mukhtar, A; Mulkey, DK; Murr, N; Mushtaq, Z; Muthuswamy, N; Mutlu, O; Muto, C; Myroforou, I; Na, KJ; Nabi, M; Nagornov, KO; Nagy, RJ; Naik, A; Nakajima, K; Nam, KT; Nam, YW; Namburath, M; Nammour, S; Namour, A; Namour, M; Nanan, S; Natsume, H; Nave, S; Naveed, A; Nazir, H; Ndubaku, C; Nedospasov, SA; Neradilek, MB; Newcomb, C; Nguépy Keubo, FR; Nguyen, M; Ning, J; Ning, Q; Noguchi, S; Nordahl, SHG; Nordfalk, KF; Norton, L; Noupoue, EM; Nouri, SS; Nowak, JK; Núñez, K; Oakes, K; Odegaard, JI; Ogorodnikova, OL; Ogunsuyi, O; Oh, HK; Oh, HR; Oh, KH; Ohgi, K; Okunade, KS; Oliveira, AG; Olorunfemi, G; Olsen, ML; Olson, BA; Omari, KW; Ondruschka, B; Orfali, R; Orkopoulos, A; Orlowski, RZ; Oser, SM; Oser, TK; Özcan, M; Padilla, V; Paeng, JC; Pajuelo-Lozano, N; Pal, SK; Palmieri, S; Palomeque, E; Pan, W; Panagiotakos, DB; Pandey, M; Pang, D; Pang, Q; Pangarah, CA; Panny, A; Paparella, A; Papirio, S; Papouskova, K; Parang, K; Park, HJ; Park, IK; Park, S; Parker, TL; Parkhomenko, A; Parmon, VN; Parsons, B; Parsons, J; Patel, PR; Patil, S; Patsourakos, NG; Patterson, KC; Pavlidis, P; Pedernera, M; Pedersen, R; Pedraza-Chaverri, J; Pellegrini, M; Peña-Chora, G; Pereira, EDM; Pereira, MADS; Peretz, A; Perez-Padilla, R; Perlman, GY; Perona, R; Petras, C; Phuntsho, S; Picada, JN; Pinder, TA; Piper, LFJ; Pirozzi, F; Pirro, M; Pleckaityte, M; Ploutz-Snyder, LL; Ploutz-Snyder, R; Pogorzelski, A; Poles, L; Postma, AA; Prager, A; Prakash, J; Punn, R; Pützer, BM; Qi, J; Qi, MC; Qi, Y; Qian, J; Qian, Y; Qiang, L; Qiu, J; Qu, Y; Rabiu, KA; Rahighi, S; Rahman, MM; Rahmani, B; Rajkumar, SV; Ramanathan, R; Raras, TYM; Rashi, Y; Rasool, G; Rathore, MG; Ratnawati, R; Ratola, N; Raucci, U; Ray, SK; Razavi, P; Razazi, K; Razek, S; Razi, SS; Reback, M; Reddy, K; Rees, DC; Reginatto, FH; Reich, H; Reis-Filho, JS; Ren, X; Ren, Y; Renner, G; Rey, G; Reymen, B; Riaz, M; Ricci, A; Richardson, PG; Richter, C; Riga, M; Ritchie, C; Rivoal, S; Roberts, W; Robson, ME; Rocha, GZ; Rodrigues, AD; Rogach, AL; Rojas, A; Rosenberg, A; Rosenberg, E; Rosenheck, RA; Roslan, K; Rothenberger, C; Rouschop, KMA; Rubagumya, F; Ryan, CM; Ryder, JW; Saad, MJA; Sacan, O; Sacchi, A; Sahebkar, A; Saini, A; Sainz, B; Sajo, EA; Sakizadeh, J; Saleh, AA; Salgado Júnior, IB; Salvi, R; Samoylova, YV; Samuni, A; Sanchez, DM; Sanchez-Perez, I; Santos, M; Sarapulova, A; Sardot, T; Saud, N; Sauerbier, P; Scaltriti, M; Schaeffer, B; Schalk, DL; Scherschel, K; Schijven, MP; Schreuder, HWR; Schuhmacher, M; Schultz-Lebahn, A; Schwarzl, J; Scott, JM; Sebayang, SK; Seeger, ZL; Segabinazi Peserico, C; Selenica, P; Serio, A; Seruga, B; Shah, A; Shah, C; Shah, PD; Shahrokh Tehraninezhad, E; Shan, A; Shao, Z; Sharma, AMR; Sharma, RK; Shen, J; Shen, R; Shi, X; Shi, Y; Shi, ZE; Shih, YC; Shimohata, H; Shimpi, N; Shin, SH; Shon, HK; Shuvy, M; Siddique, AB; Siegbahn, A; Sikandar, M; Silvani, Y; Singh, A; Singh, AK; Singh, D; Singh, JS; Singh, KP; Singh, M; Situ, B; Skipper, MT; Skouloudi, M; Sloane, BF; Smyrnioudis, N; Snyder, MA; Söhnchen, C; Solis Condor, R; Solit, DB; Someya, S; Song, H; Song, J; Song, W; Song, Y; Sorokina, KN; Soshi, S; Soyer, P; Spitschak, A; Sreekrishnan, TR; Srinivasan, M; Staruschenko, A; Steel, A; Stefan-van Staden, RI; Stein, AM; Strayer, H; Struthers, AD; Su, H; Su, Q; Su, X; Sudore, RL; Sugimura, H; Sugiyama, Y; Sujuti, H; Sumner, SJ; Sun, B; Sun, D; Sun, H; Sun, J; Sun, JY; Sun, X; Sun, Y; Sun, Z; Sung, YC; Surenaud, M; Sutimantanapi, D; Suwandaratne, NS; Swaroop, S; Sychrova, H; Syed, A; Szczepanik, M; Szederjesi, J; Szodorai, R; Tacy, TA; Tadelle, RM; Takayasu, M; Tammeveski, K; Tan, H; Tan, M; Tang, HX; Tang, S; Tang, X; Tanokura, M; Tao, F; Tao, H; Tarafdari, A; Tarín-Carrasco, P; Tasson Tatang, C; Teixeira, JP; Thakur, A; Theobald, A; Thevenot, P; Thomaidis, K; Tian, J; Tillib, SV; Toma, C; Tomita, M; Tonchev, I; Tong, F; Toy, W; Trypuć, M; Tselepis, AD; Tsetseris, L; Tsikouri, GE; Tsikouris, EI; Tsoplifack, CB; Tsoumani, ME; Tsujimoto, R; Tsybin, YO; Tu, J; Tu, TM; Turco, M; Turkyilmaz, IB; Uddin, MJ; Ung, J; Unsihuay, D; Utsunomiya, T; Vagenende, B; Vaishnav, J; Valdes, C; Validad, MH; Valle, J; van Ginkel, MPH; van Grevenstein, WMU; Vanderpuye, V; Vasan, N; Vasilenko, EA; Vasques, GJ; Vavoulis, P; Verani, A; Veziroglu, E; Viegas, A; Vitali, MG; Vitsas, G; Voccio, JP; Vogiatzidis, C; Volow, A; Volpin, F; Vourvahis, M; Wagner, LI; Walkowiak, J; Wallace, R; Wallentin, L; Wan, D; Wan, L; Wan, T; Wang, C; Wang, F; Wang, FN; Wang, H; Wang, J; Wang, L; Wang, Q; Wang, S; Wang, T; Wang, W; Wang, X; Wang, XW; Wang, Y; Wang, YS; Wang, Z; Ward, J; Ward, L; Waseem, R; Watson, DF; Weber, P; Wehrmeister, FC; Wei, CH; Wei, H; Wei, L; Wei, Q; Wei, Y; Weinstock, RS; Weiss, M; Welborn, M; Wen, L; Wen, LM; Wen, Q; Wen, Z; Wesseling, P; Westerbergh, J; White, K; Wick, MP; Willems, S; Wiyasa, IWA; Wójciak, R; Wolkenhauer, O; Won, HH; Wong, J; Woo, YC; Wood, LS; Wu, CT; Wu, CY; Wu, D; Wu, G; Wu, J; Wu, K; Wu, M; Wu, Q; Wu, T; Wu, W; Wu, X; Wu, XT; Wu, Y; Xi, D; Xi, J; Xiang, W; Xiang, Y; Xiao, M; Xiao, Z; Xie, H; Xie, Q; Xie, S; Xie, X; Xing, M; Xing, YL; Xu, C; Xu, X; Xu, Y; Xu, Z; Xue, F; Xue, XD; Yaglioglu, HG; Yamada, H; Yamashita, M; Yan, W; Yan, Z; Yanardag, R; Yang, D; Yang, H; Yang, K; Yang, QQ; Yang, R; Yang, S; Yang, T; Yang, X; Yang, Y; Yao, H; Yao, Y; Yari, D; Yassin, MT; Ye, C; Ye, J; Ye, Q; Yildiz, EA; Ying, S; Yoon, H; Yu, D; Yu, K; Yu, N; Yu, PL; Yuan, C; Yuan, D; Yuan, LJ; Yuan, Z; Yuen, N; Zagatto, AM; Zakaria, Y; Zalewski, AM; Zamora, S; Zavorotinskaya, T; Zeid, JL; Zeinoun, T; Zeng, C; Zerby, HN; Zhan, X; Zhang, A; Zhang, D; Zhang, E; Zhang, F; Zhang, H; Zhang, J; Zhang, L; Zhang, M; Zhang, P; Zhang, Q; Zhang, QY; Zhang, RG; Zhang, S; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, CK; Zhao, H; Zhao, J; Zhao, K; Zhao, Q; Zhao, S; Zhao, T; Zhao, XQ; Zhao, Y; Zhao, Z; Zheng, J; Zheng, L; Zheng, Y; Zhou, B; Zhou, G; Zhou, L; Zhou, T; Zhou, X; Zhu, C; Zhu, J; Zhu, Y; Zhu, ZQ; Zhuang, T; Zimmermannova, O; Zin, NNINM; Zisimos, K; Zoghebi, KA; Zonder, JA; Zou, C; Zwirner, J | 1 |
Chen, G; Dong, S; Dong, Y; Feng, L; He, F; Li, W; Liu, S; Sun, Q; Wang, Z; Yang, P | 1 |
Du, X; Hu, J; Li, X; Zhang, C | 1 |
Bangar, P; Chaudhari, P; Dhas, N; Garg, N; Garkal, A; Ghate, V; Khot, S; Kudarha, R; Lewis, S; Mehta, T; Panzade, P; Paryani, M; Sharma, S; Singh, A; Singh, N | 1 |
Chen, L; Fu, L; He, C; Kang, L; Li, D; Li, M; Yang, S; You, Y; You, Z; Zhou, X | 1 |
Lin, K; Wang, S; Wu, H; Yin, Y; Zhang, Z; Zhao, J | 1 |
Moniri, E; Panahi, HA; Soltani, ER; Tahvildari, K | 1 |
Jiang, C; Lu, L; Sun, W; Wang, W; Yu, B | 1 |
Feng, W; Li, F; Li, L; Liu, Y; Ma, L; Wei, Z; Zhou, J; Zhu, X | 1 |
Fan, Y; Hu, W; Li, D; Li, Y; Shen, M; Shi, X; Wang, X; Xiao, T; Xing, L | 1 |
Adeli, M; Haag, R; Nie, C; Pan, Y; Xu, S; Zhong, Y | 1 |
Cheng, SX; Peng, MY; Wang, SB; Zhang, XZ; Zheng, DW | 1 |
Benbrahim-Tallaa, L; Bouvard, V; El Ghissassi, F; Grosse, Y; Guha, N; Guyton, KZ; Loomis, D; Muller, K; Straif, K; Vilahur, N | 1 |
Cai, S; Han, Q; Jia, X; Liang, W; Qin, Y; Wang, C; Wang, X; Yang, R | 1 |
Bharwani, Z; Chen, S; Farokhzad, OC; Guo, Z; Islam, MA; Ji, X; Li, Z; Saw, PE; Shi, J; Tao, W; Xu, X; Zhang, H | 1 |
He, G; Li, B; Lu, X; Parkin, IP; Wang, FR; Wang, X; Wu, X; Xu, R | 1 |
Jay, M; Kim, J; Lu, X; Narayan, RJ | 1 |
Barrett, A; Bharwani, Z; Cai, T; Chen, H; Chen, Y; Ding, L; Farokhzad, OC; Gan, T; Ji, X; Kong, N; Li, Y; Mahmoudi, M; Tao, W; Xu, X; Zhu, X | 1 |
Aureliano, M; Bijelic, A; Rompel, A | 1 |
Cheng, L; Gong, F; Jin, Q; Li, Y; Liu, Z; Tian, L; Wang, M; Yang, N | 1 |
Adawi, AM; Bouillard, JG; Efremova, OA; Eling, CJ; Eltsov, IV; Evtushok, DV; Fufaeva, MS; Ivanov, AA; Kuratieva, NV; Mironov, YV; Miroshnichenko, SM; Pozmogova, TN; Shestopalov, MA; Shestopalova, LV; Solovieva, AO; Svezhentseva, EV; Vorotnikov, YA; Yanshole, VV | 1 |
Chung, K; Kim, DH; Lee, H; Lim, JW; Maji, SK; Sekkarapatti Ramasamy, M; Wang, J; Yu, S | 1 |
Cui, F; Ding, H; Ji, J; Lu, Y; Sun, J; Sun, X; Wang, H; Wang, J; Xu, D; Zhang, Y | 1 |
Chen, W; Fang, T; Huang, G; Li, G; Liu, Y; Sheng, Y; Su, J; Tang, Q; Yuan, S; Zang, J; Zhang, X | 1 |
Cheng, Y; Li, N; Li, P; Liu, L; Lu, Q; Song, Y; Tan, F; Wang, S; Wang, Y; Yang, L; Yang, S | 1 |
Jia, J; Luo, Z; Su, G; Yan, B; Yue, T; Zhou, X | 1 |
Bian, F; Cai, L; Sun, L; Wang, S; Wang, Y; Zhao, Y; Zhou, M | 1 |
Jia, L; Li, B; Li, F; Liu, J; Zhang, D; Zheng, J | 1 |
Liu, J; Qu, Y; Tian, Y; Zheng, T | 1 |
An, L; Chen, Z; Hu, J; Hu, R; Jiang, F; Li, W; Qin, Z; Shen, J; Song, G; Zou, R | 1 |
Adam, J; Kadeřávek, J; Kužel, F; Rehák, Z; Vašina, J | 1 |
Brewer, GJ | 4 |
Chng, EL; Pumera, M; Sofer, Z | 1 |
Galani, A; Karaliota, A; Psycharis, V; Raptopoulou, CP; Stellas, D; Tsitsias, V | 1 |
An, X; Cai, X; Chen, H; Chen, Y; Gao, W; Li, X; Shi, J; Wang, S; Yao, H; Zheng, Y | 1 |
Bao, T; Dong, X; Gu, Z; Ma, X; Tian, G; Wang, Z; Yin, W; Yu, J; Zhang, X; Zhao, Y; Zheng, X | 1 |
Du, D; Lin, Y; Yang, G; Zhu, C; Zhu, J | 1 |
He, Y; Li, J; Liu, Y | 1 |
Chen, H; Chen, Y; Gao, W; Li, X; Liu, J; Shi, J; Wang, S; Zhang, L; Zheng, Y | 1 |
Abelman, S; Kim, KK; Moore, RG; Ribeiro, JR; Singh, RK; Tipping, M; Yano, N | 1 |
Bao, T; Dong, X; Gao, F; Gu, Z; Yan, L; Yin, W; Yong, Y; Yu, J; Zhang, X; Zhao, Y; Zheng, X | 1 |
Luo, Z; Shan, J; Teng, Z; Wang, L; Weng, L; Yuwen, L; Zhang, Q; Zhang, Y; Zhou, J | 1 |
Deivasigamani, A; Han, J; Hui, KM; Kang, Y; Kong, SN; Wu, Y; Xia, H; Xu, R | 1 |
Adams, A; Donate, F; Fisher, N; Harris, AL; Hayward, C; Joel, S; Lowndes, SA; Mazar, A; Middleton, M; Reich, S; Smythe, J; Timms, A; Watt, SM | 1 |
Abnet, CC; Dawsey, SM; Dong, ZW; Fan, JH; Gail, MH; Johnson, LL; Kamangar, F; Mark, SD; Qiao, YL; Sun, XD; Taylor, PR; Yu, B | 1 |
Khan, G; Merajver, S | 1 |
Hanahan, D; Ishida, S; McCormick, F; Smith-McCune, K | 1 |
Almeida, J; Bandarra, D; Brandão, P; Calhorda, MJ; Félix, V; Lopes, M; Lopes, T; Meireles, M; Nunes, CD; Saraiva, MS; Vasconcellos-Dias, M; Vaz, PD | 1 |
Silari, M | 1 |
Alvarez-Breckenridge, CA; Bratasz, A; Chiocca, EA; Glorioso, JC; Haseley, A; Kaka, A; Kaur, B; Mazar, AP; Old, M; Powell, K; Pradarelli, J; Teknos, TN; Wojton, J; Yoo, JY; Yu, JG | 1 |
Suttle, NF | 1 |
Brechbiel, M; Camphausen, K; Sproull, M | 1 |
PINSENT, J | 1 |
MUKHERJEE, HN | 4 |
ARCHAMBAULT, M; SORENSEN, LB | 1 |
Brewer, GJ; Merajver, SD | 1 |
Harris, ED | 1 |
Brewer, GJ; Goodman, VL; Merajver, SD | 2 |
Hasenknopf, B | 1 |
Bu, H; Sun, X | 1 |
Eriguchi, M; Hisa, T; Mitsui, S; Ogata, A; Yamase, T; Yanagie, H | 1 |
Harris, AL; Lowndes, SA | 1 |
Brewer, GJ; Dick, R; Hou, G; Zeng, C | 1 |
Sorenson, JR; Wangila, GW | 1 |
Khan, GN; Merajver, SD | 1 |
Sardesai, VM | 1 |
Brewer, GJ; Dick, RD; Grover, DK; Jahan, T; LeCarpentier, G; LeClaire, V; Merajver, SD; Pienta, K; Redman, BG; Sondak, VK; Strawderman, M; Tseng, M; Wicha, M | 1 |
Vanchieri, C | 1 |
Boone, CW; Fay, JR; Kelloff, GJ; Malone, WF; Sigman, CC | 1 |
Duch, DS; Nichol, CA; Smith, GK | 1 |
Owen, AG; Owen, LN | 1 |
Deelstra, H; Robberecht, H; Roekens, E | 1 |
Allaway, WH | 1 |
Krzymień, H | 1 |
25 review(s) available for molybdenum and Neoplasms
Article | Year |
---|---|
Molybdenum disulfide nanosheets: From exfoliation preparation to biosensing and cancer therapy applications.
Topics: Biosensing Techniques; Disulfides; Humans; Molybdenum; Nanostructures; Neoplasms | 2020 |
Recent advances in MoS
Topics: Animals; Anti-Infective Agents; Antineoplastic Agents; Contrast Media; Disulfides; Humans; Immunotherapy; Infections; Molybdenum; Neoplasms; Photothermal Therapy | 2020 |
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
Molybdenum-based hetero-nanocomposites for cancer therapy, diagnosis and biosensing application: Current advancement and future breakthroughs.
Topics: Disulfides; Humans; Immunotherapy; Molybdenum; Nanocomposites; Neoplasms; Phototherapy | 2021 |
Polyoxometalates as Potential Next-Generation Metallodrugs in the Combat Against Cancer.
Topics: Animals; Antineoplastic Agents; Drug Discovery; Humans; Models, Molecular; Molybdenum; Neoplasms; Niobium; Organometallic Compounds; Tungsten; Tungsten Compounds; Vanadium | 2019 |
The promise of copper lowering therapy with tetrathiomolybdate in the cure of cancer and in the treatment of inflammatory disease.
Topics: Animals; Clinical Trials as Topic; Copper; Dogs; Humans; Inflammation; Molybdenum; Neoplasms; Osteosarcoma | 2014 |
Copper chelation in cancer therapy using tetrathiomolybdate: an evolving paradigm.
Topics: Animals; Antineoplastic Agents; Chelating Agents; Copper; Hepatolenticular Degeneration; Humans; Molybdenum; Neoplasms | 2009 |
Applications of particle accelerators in medicine.
Topics: Carbon; Electrons; Humans; Ions; Molybdenum; Neoplasms; Particle Accelerators; Proton Therapy; Radioisotopes; Radiotherapy, High-Energy | 2011 |
Copper imbalances in ruminants and humans: unexpected common ground.
Topics: Alzheimer Disease; Animals; Chelating Agents; Copper; Deficiency Diseases; Enzyme Inhibitors; Hepatolenticular Degeneration; Humans; Infections; Inflammation; Molybdenum; Neoplasms; Nutritional Requirements; Ruminants | 2012 |
Antiangiogenic therapy through copper chelation.
Topics: Angiogenesis Inhibitors; Animals; Chelating Agents; Chelation Therapy; Copper; Corneal Neovascularization; Cyclohexylamines; Hepatolenticular Degeneration; Humans; Molybdenum; Neoplasms; Neovascularization, Pathologic; Penicillamine; Pyridines; Rabbits; Trientine | 2003 |
Cancer therapy with tetrathiomolybdate: antiangiogenesis by lowering body copper--a review.
Topics: Angiogenesis Inhibitors; Animals; Chelating Agents; Copper; Humans; Molybdenum; Neoplasms | 2002 |
A requirement for copper in angiogenesis.
Topics: Animals; Apoptosis; Cell Division; Chelating Agents; Copper; Cornea; Growth Substances; Humans; Molybdenum; Neoplasms; Neovascularization, Pathologic; Nutritional Requirements | 2004 |
Copper deficiency as an anti-cancer strategy.
Topics: Angiogenesis Inhibitors; Animals; Chelating Agents; Copper; Humans; Molybdenum; Neoplasms; Neovascularization, Pathologic | 2004 |
Polyoxometalates: introduction to a class of inorganic compounds and their biomedical applications.
Topics: Animals; Anti-Bacterial Agents; Antineoplastic Agents; Antiviral Agents; Cations; Diabetes Mellitus; Humans; Infections; Inorganic Chemicals; Metals; Molybdenum; Neoplasms; Tungsten; Vanadates | 2005 |
Copper lowering therapy with tetrathiomolybdate as an antiangiogenic strategy in cancer.
Topics: Angiogenesis Inhibitors; Animals; Copper; Humans; Molybdenum; Neoplasms | 2005 |
Anticopper therapy against cancer and diseases of inflammation and fibrosis.
Topics: Animals; Copper; Fibrosis; Humans; Inflammation; Molybdenum; Neoplasms; Neovascularization, Pathologic; Penicillamine; Trientine | 2005 |
Control of copper status for cancer therapy.
Topics: Angiogenesis Inhibitors; Animals; Chelating Agents; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Copper; Humans; Molybdenum; Neoplasms | 2005 |
Anticancer activity of polyoxomolybdate.
Topics: Animals; Antineoplastic Agents; Humans; Molybdenum; Neoplasms; Oxides | 2006 |
The role of copper in tumour angiogenesis.
Topics: Animals; Biological Transport; Copper; Disease Models, Animal; Endothelial Cells; Humans; Models, Biological; Models, Chemical; Molybdenum; Neoplasms; Neovascularization, Pathologic; Prognosis; Up-Regulation | 2005 |
Co-treatment with copper compounds dramatically decreases toxicities observed with cisplatin cancer therapy and the anticancer efficacy of some copper chelates supports the conclusion that copper chelate therapy may be markedly more effective and less tox
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Chelating Agents; Cisplatin; Copper; Humans; Molybdenum; Neoplasms; Organometallic Compounds | 2007 |
Modulation of angiogenesis for cancer prevention: strategies based on antioxidants and copper deficiency.
Topics: Angiogenesis Inhibitors; Animals; Anticarcinogenic Agents; Antioxidants; Breast Neoplasms; Carotenoids; Cell Transformation, Neoplastic; Chelating Agents; Copper; Dietary Supplements; Female; Flavonoids; Head and Neck Neoplasms; Humans; Lung Neoplasms; Male; Molybdenum; Neoplasms; Neovascularization, Pathologic; NF-kappa B; Phenols; Polyphenols; Prostatic Neoplasms; Reactive Oxygen Species | 2007 |
Copper control as an antiangiogenic anticancer therapy: lessons from treating Wilson's disease.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Copper; Hepatolenticular Degeneration; Humans; Molybdenum; Neoplasms; Zinc | 2001 |
Progress in applied chemoprevention research.
Topics: Animals; Antineoplastic Agents; Dehydroepiandrosterone; Drug Evaluation; Eflornithine; Fenretinide; Humans; Molybdenum; Neoplasms; Piroxicam; Tretinoin | 1990 |
Biosynthesis and metabolism of tetrahydrobiopterin and molybdopterin.
Topics: Alcohol Oxidoreductases; Animals; Biopterins; Body Fluids; Coenzymes; GTP Cyclohydrolase; Humans; Immune System Diseases; Mental Disorders; Metalloproteins; Molybdenum; Molybdenum Cofactors; Neoplasms; Nervous System Diseases; Phenylalanine; Phenylketonurias; Pteridines; Pterins; Tetrahydrofolate Dehydrogenase; Tissue Distribution; Tryptophan Hydroxylase; Tyrosine 3-Monooxygenase | 1985 |
Trace elements in human milk, selenium a case study.
Topics: Arsenic; Chromium; Cobalt; Copper; Female; Heart Diseases; Humans; Iron; Longitudinal Studies; Manganese; Milk, Human; Molybdenum; Neoplasms; Parenteral Nutrition, Total; Pregnancy; Selenium; Trace Elements; Zinc | 1985 |
4 trial(s) available for molybdenum and Neoplasms
Article | Year |
---|---|
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
Phase I study of copper-binding agent ATN-224 in patients with advanced solid tumors.
Topics: Adult; Aged; Ceruloplasmin; Chelating Agents; Chelation Therapy; Choline; Copper; Cytokines; Endothelial Cells; Female; Humans; Male; Maximum Tolerated Dose; Middle Aged; Molybdenum; Neoplasms; Superoxide Dismutase | 2008 |
Total and cancer mortality after supplementation with vitamins and minerals: follow-up of the Linxian General Population Nutrition Intervention Trial.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; alpha-Tocopherol; Antioxidants; Ascorbic Acid; beta Carotene; China; Confounding Factors, Epidemiologic; Dietary Supplements; Diterpenes; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Male; Malnutrition; Micronutrients; Middle Aged; Molybdenum; Neoplasms; Niacin; Odds Ratio; Retinyl Esters; Riboflavin; Risk Factors; Selenium; Vitamin A; Vitamins; Zinc Oxide | 2009 |
Treatment of metastatic cancer with tetrathiomolybdate, an anticopper, antiangiogenic agent: Phase I study.
Topics: Adult; Angiogenesis Inhibitors; Animals; Biomarkers; Ceruloplasmin; Copper; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Male; Mice; Middle Aged; Molybdenum; Neoplasm Metastasis; Neoplasms | 2000 |
80 other study(ies) available for molybdenum and Neoplasms
Article | Year |
---|---|
MoS
Topics: Biomarkers, Tumor; Biosensing Techniques; Electrochemical Techniques; Gold; Humans; Limit of Detection; Metal Nanoparticles; MicroRNAs; Molybdenum; Neoplasms; Titanium | 2022 |
Enhancing Tumor Catalytic Therapy by Co-Catalysis.
Topics: Catalysis; Humans; Hydrogen Peroxide; Molybdenum; Neoplasms; Oxidation-Reduction | 2022 |
Development of a magnetic MoS
Topics: Animals; Cell Line, Tumor; Doxorubicin; Drug Liberation; Humans; Hyperthermia, Induced; Lipids; Magnetic Phenomena; Mice; Molybdenum; Nanoparticles; Neoplasms; Phototherapy | 2022 |
Synthetic and Biodegradable Molybdenum(IV) Diselenide Triggers the Cascade Photo- and Immunotherapy of Tumor.
Topics: Catalase; CD8-Positive T-Lymphocytes; Cell Line, Tumor; Humans; Immunotherapy; Molybdenum; Nanoparticles; Neoplasms; Photochemotherapy; Photosensitizing Agents; Porphyrins; Tumor Microenvironment | 2022 |
NIR-II Responsive Molybdenum Dioxide Nanosystem Manipulating Cellular Immunogenicity for Enhanced Tumor Photoimmunotherapy.
Topics: Cell Line, Tumor; Humans; Immunotherapy; Molybdenum; Nanoparticles; Neoplasms; Oxides; Phototherapy | 2022 |
Injectable and Self-Healing Polysaccharide Hydrogel Loading Molybdenum Disulfide Nanoflakes for Synergistic Photothermal-Photodynamic Therapy of Breast Cancer.
Topics: Disulfides; Humans; Hydrogels; Molybdenum; Nanogels; Neoplasms; Photochemotherapy; Phototherapy; Polysaccharides; Serum Albumin, Bovine | 2022 |
MoS
Topics: Animals; Catalysis; Cell Line, Tumor; Doxorubicin; Mice; Molybdenum; Nanomedicine; Nanoparticles; Neoplasms; Water | 2022 |
Piezo-Activated Atomic-Thin Molybdenum Disulfide/MXene Nanoenzyme for Integrated and Efficient Tumor Therapy via Ultrasound-Triggered Schottky Electric Field.
Topics: Chitosan; Humans; Molybdenum; Neoplasms; Tumor Microenvironment | 2023 |
Oxygen-Deficient Molybdenum Oxide Nanosensitizers for Ultrasound-Enhanced Cancer Metalloimmunotherapy.
Topics: Cell Line, Tumor; Humans; Hypoxia; Molybdenum; Neoplasms; Oxides; Oxygen; Reactive Oxygen Species | 2023 |
A single-step plasma method for rapid production of 2D, ferromagnetic, surface vacancy-engineered MoO
Topics: Animals; Humans; Mice; Molybdenum; Nanostructures; Neoplasms; Oxides; Phototherapy | 2023 |
Photothermal Attenuation of Cancer Cell Stemness, Chemoresistance, and Migration Using CD44-Targeted MoS
Topics: Antineoplastic Agents; Cell Differentiation; Cell Line, Tumor; Drug Resistance, Neoplasm; Molybdenum; Neoplasms | 2023 |
Photo-/piezo-activated ultrathin molybdenum disulfide nanomedicine for synergistic tumor therapy.
Topics: Humans; Molybdenum; Nanomedicine; Neoplasms; Phototherapy | 2023 |
Vacancy Augmented Piezo-Sonosensitizer for Cancer Therapy.
Topics: Humans; Molybdenum; Neoplasms; Reactive Oxygen Species; Ultrasonic Therapy | 2023 |
Construction of electrochemical biosensors based on MoSe
Topics: Animals; Biomarkers, Tumor; Biosensing Techniques; Electrochemical Techniques; Limit of Detection; Mice; MicroRNAs; Molybdenum; Neoplasms; Reproducibility of Results | 2023 |
Quantitative measurement of CA 15-3 cancer biomarker using an electrochemical aptasensor based on the electrodeposition of Au thin film on cauliflower-like rGO-MoS
Topics: Biomarkers, Tumor; Electroplating; Humans; Molybdenum; Mucin-1; Nanocomposites; Neoplasms; Oligonucleotides | 2023 |
Porous Molybdenum Nitride Nanosphere as Carrier-Free and Efficient Nitric Oxide Donor for Synergistic Nitric Oxide and Chemo/Sonodynamic Therapy.
Topics: Cell Line, Tumor; Humans; Molybdenum; Nanospheres; Neoplasms; Nitric Oxide; Nitric Oxide Donors; Porosity; Reactive Oxygen Species; Tumor Microenvironment; Ultrasonic Therapy | 2023 |
Controllable growth of Au nanostructures onto MoS
Topics: Animals; Cell Line, Tumor; Electrochemistry; Female; Gold; Hyperthermia, Induced; Light; Metal Nanoparticles; Mice; Mice, Inbred BALB C; Molybdenum; Nanostructures; Nanotechnology; Neoplasm Transplantation; Neoplasms; Oxygen; Photoacoustic Techniques; Photochemistry; Phototherapy; Polymers; Spectrophotometry, Infrared; Surface Properties; Theranostic Nanomedicine; Tomography, X-Ray Computed; X-Rays | 2019 |
Glutathione Depletion in a Benign Manner by MoS
Topics: Cell Line, Tumor; Disulfides; Free Radicals; Glutathione; Humans; Molybdenum; Neoplasms; Polyethylene Glycols; Reactive Oxygen Species | 2019 |
Layered MoS
Topics: Animals; Antineoplastic Agents; Biomimetic Materials; Cell Death; Cell Survival; Combined Modality Therapy; Disulfides; Doxorubicin; Drug Liberation; Humans; Hyperthermia, Induced; MCF-7 Cells; Mice, Inbred ICR; Molybdenum; Nanoparticles; Neoplasms; Phospholipids; Phototherapy; Serum Albumin, Bovine; Spectroscopy, Fourier Transform Infrared | 2020 |
Spontaneous reduction of KMnO
Topics: Animals; Aptamers, Nucleotide; Biocompatible Materials; Cell Line, Tumor; Cell Survival; Disulfides; Glutathione; Humans; Magnetic Resonance Imaging; Mice; Mice, Inbred BALB C; Molybdenum; Neoplasms; Oxidation-Reduction; Potassium Permanganate; Quantum Dots | 2020 |
A bioconjugated MoS
Topics: Antibodies, Monoclonal; Antigens, Neoplasm; Carbonic Anhydrase IX; Cell Line, Tumor; Cell Proliferation; Cell Survival; Disulfides; Flow Cytometry; Humans; Molybdenum; Nanostructures; Neoplasms | 2020 |
A simple POM clusters for in vivo NIR-II photoacoustic imaging-guided NIR-II photothermal therapy.
Topics: Animals; Anions; Cell Line, Tumor; Humans; Infrared Rays; Mice; Molybdenum; Nanoparticles; Neoplasms; Photoacoustic Techniques; Photothermal Therapy; Polyelectrolytes; Theranostic Nanomedicine | 2020 |
Cancer Pro-oxidant Therapy Through Copper Redox Cycling:
Topics: Cell Line, Tumor; Copper; Disulfiram; Drug Repositioning; Humans; Hydrogen Peroxide; Molybdenum; Neoplasms; Oxidation-Reduction; Reactive Oxygen Species | 2020 |
MoS
Topics: Cell Line, Tumor; Glucose Oxidase; Humans; Hydrogels; Hydrogen Peroxide; Molybdenum; Neoplasms | 2020 |
Multimode Imaging-Guided Photothermal/Chemodynamic Synergistic Therapy Nanoagent with a Tumor Microenvironment Responded Effect.
Topics: Animals; Biocompatible Materials; Cell Line; Cell Survival; Contrast Media; Glutathione; Humans; Hydrogen Peroxide; Mice; Molybdenum; Multimodal Imaging; Nanoparticles; Neoplasms; Oxides; Photochemotherapy; Photothermal Therapy; Polyethylene Glycols; Porosity; Silicon Dioxide; Singlet Oxygen; Tumor Microenvironment | 2020 |
An Electrochemical Sensor Based on Chalcogenide Molybdenum Disulfide-Gold-Silver Nanocomposite for Detection of Hydrogen Peroxide Released by Cancer Cells.
Topics: Disulfides; Electrochemical Techniques; Gold; Hydrogen Peroxide; Limit of Detection; Molybdenum; Nanocomposites; Neoplasms; Silver | 2020 |
Coupling metal organic frameworks with molybdenum disulfide nanoflakes for targeted cancer theranostics.
Topics: Cell Line, Tumor; Disulfides; Doxorubicin; Drug Delivery Systems; Drug Liberation; Metal-Organic Frameworks; Molybdenum; Nanoparticles; Neoplasms; Phototherapy; Precision Medicine; Theranostic Nanomedicine | 2021 |
2D LDH-MoS
Topics: Animals; Biomimetic Materials; Catalase; Chlorophyllides; Disulfides; HT29 Cells; Humans; Hydroxides; Magnetic Resonance Imaging; Mice; Molybdenum; Nanostructures; Neoplasms; Photochemotherapy; Photosensitizing Agents; Photothermal Therapy; Porphyrins; Reactive Oxygen Species; Theranostic Nanomedicine | 2021 |
NIPAM/PEG/ MoS2 Nanosheets for Dual Triggered Doxorubicin Release and Combined Chemo-photothermal Cancer Therapy.
Topics: Cell Survival; Doxorubicin; Drug Liberation; Humans; Molybdenum; Neoplasms; Photothermal Therapy; Polyethylene Glycols | 2021 |
Defect Engineering Enables Synergistic Action of Enzyme-Mimicking Active Centers for High-Efficiency Tumor Therapy.
Topics: Humans; Iron; Lasers; Molybdenum; Neoplasms; Oxidation-Reduction; Oxides; Particle Size | 2021 |
Customized Photothermal Therapy of Subcutaneous Orthotopic Cancer by Multichannel Luminescent Nanocomposites.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Disease Models, Animal; Glutathione; Humans; Infrared Rays; Lanthanoid Series Elements; Luminescent Agents; Metal Nanoparticles; Mice; Molybdenum; Nanocomposites; Neoplasms; Photothermal Therapy; Silicon Compounds; Surface Properties; Theranostic Nanomedicine | 2021 |
Intelligent Molybdenum Disulfide Complexes as a Platform for Cooperative Imaging-Guided Tri-Mode Chemo-Photothermo-Immunotherapy.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Combined Modality Therapy; Disease Models, Animal; Disulfides; Immunotherapy; Mice; Molybdenum; Nanoparticle Drug Delivery System; Neoplasms; Photoacoustic Techniques; Phototherapy; Radiography, Interventional; Tomography, X-Ray Computed | 2021 |
Co-Delivery of Doxorubicin and Chloroquine by Polyglycerol Functionalized MoS2 Nanosheets for Efficient Multidrug-Resistant Cancer Therapy.
Topics: Chloroquine; Disulfides; Doxorubicin; Drug Resistance, Neoplasm; Glycerol; HeLa Cells; Humans; Microscopy, Electron, Scanning; Microscopy, Electron, Transmission; Molybdenum; Nanostructures; Neoplasms; Polymers; Spectrophotometry, Ultraviolet | 2021 |
Multifunctional Nanosystem for Synergistic Tumor Therapy Delivered by Two-Dimensional MoS
Topics: Disulfides; Humans; Molybdenum; Nanostructures; Neoplasms; Photochemotherapy; Photosensitizing Agents; Phototherapy; Tolonium Chloride | 2017 |
Carcinogenicity of welding, molybdenum trioxide, and indium tin oxide.
Topics: Animals; Carcinogens, Environmental; Humans; Molybdenum; Neoplasms; Occupational Exposure; Occupational Health; Oxides; Risk Assessment; Tin Compounds; Welding | 2017 |
CpG loaded MoS
Topics: Animals; Cell Line, Tumor; CpG Islands; Immunotherapy; Mice; Mice, Inbred C57BL; Molybdenum; Nanoconjugates; Neoplasms; Phototherapy; RAW 264.7 Cells | 2017 |
Antimonene Quantum Dots: Synthesis and Application as Near-Infrared Photothermal Agents for Effective Cancer Therapy.
Topics: Animals; Biocompatible Materials; Cell Line, Tumor; Disulfides; Gold; Graphite; Humans; Infrared Rays; Mice; Mice, Nude; Molybdenum; Neoplasms; Phosphorus; Phototherapy; Polyethylene Glycols; Quantum Dots; Spectrum Analysis; Surface Properties; Xenograft Model Antitumor Assays | 2017 |
Phase and morphological control of MoO
Topics: Animals; Cell Line, Tumor; Humans; Hydrophobic and Hydrophilic Interactions; Mice; Molybdenum; Nanostructures; Neoplasms; Oxides; Oxygen; Phototherapy; Theranostic Nanomedicine | 2017 |
Neutron-activatable needles for radionuclide therapy of solid tumors.
Topics: Brachytherapy; Coated Materials, Biocompatible; Drug Delivery Systems; Equipment Design; Holmium; Humans; Molybdenum; Needles; Neoplasms; Neutrons; Rhenium; Titanium; Transdermal Patch | 2017 |
Intracellular Mechanistic Understanding of 2D MoS
Topics: Animals; Antibiotics, Antineoplastic; Autophagy; Disulfides; Doxorubicin; Endocytosis; Exocytosis; HeLa Cells; Humans; Lysosomes; MCF-7 Cells; Mice, Inbred BALB C; Molybdenum; Nanostructures; Neoplasms | 2018 |
Bimetallic Oxide MnMoO
Topics: Animals; Glutathione; Hyperthermia, Induced; Manganese Compounds; Mice; Molybdenum; Nanotubes; Neoplasms; Oxides; Photoacoustic Techniques; Phototherapy; Theranostic Nanomedicine; Tumor Microenvironment | 2018 |
From Photoinduced to Dark Cytotoxicity through an Octahedral Cluster Hydrolysis.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Drug Stability; Hep G2 Cells; Humans; Hydrolysis; Light; Models, Molecular; Molybdenum; Neoplasms; Photochemical Processes; Photosensitizing Agents; Tungsten | 2018 |
Synergistic Nanozymetic Activity of Hybrid Gold Bipyramid-Molybdenum Disulfide Core@Shell Nanostructures for Two-Photon Imaging and Anticancer Therapy.
Topics: Cell Line, Tumor; Disulfides; Gold; Humans; Microscopy, Fluorescence, Multiphoton; Molybdenum; Nanoparticles; Neoplasms; Photochemotherapy | 2018 |
A novel magnetic fluorescent biosensor based on graphene quantum dots for rapid, efficient, and sensitive separation and detection of circulating tumor cells.
Topics: A549 Cells; Aptamers, Nucleotide; Biosensing Techniques; Cell Separation; Disulfides; Epithelial Cell Adhesion Molecule; Equipment Design; Ferrosoferric Oxide; Fluorescent Dyes; Graphite; HEK293 Cells; Hep G2 Cells; Humans; Molybdenum; Nanostructures; Neoplasms; Neoplastic Cells, Circulating; Quantum Dots | 2019 |
Tetrathiomolybdate induces dimerization of the metal-binding domain of ATPase and inhibits platination of the protein.
Topics: Antineoplastic Agents; Chelating Agents; Cisplatin; Copper; Copper-Transporting ATPases; Cross-Linking Reagents; Crystallography, X-Ray; Cysteine; Drug Resistance, Neoplasm; Drug Synergism; Enzyme Inhibitors; Humans; Molybdenum; Neoplasms; Platinum; Protein Interaction Domains and Motifs; Protein Multimerization; Protein Structure, Secondary | 2019 |
Ultrasmall MoS
Topics: Animals; Cell Line, Tumor; Cell Survival; Chlorophyllides; Disulfides; Humans; Hyaluronic Acid; Mice; Microscopy, Confocal; Molybdenum; Multimodal Imaging; Nanocomposites; Nanoparticles; Neoplasms; Photochemotherapy; Photosensitizing Agents; Phototherapy; Porphyrins; Quantum Dots; Silicon Dioxide; Singlet Oxygen; Transplantation, Heterologous | 2019 |
Remote Induction of Cell Autophagy by 2D MoS
Topics: Autophagy; Cell Line, Tumor; Disulfides; Humans; Molybdenum; Nanoparticles; Neoplasm Proteins; Neoplasms; Receptors, Cell Surface; Signal Transduction; TOR Serine-Threonine Kinases | 2019 |
Molybdenum disulfide-integrated photonic barcodes for tumor markers screening.
Topics: Biomarkers, Tumor; Biosensing Techniques; Colloids; Disulfides; Humans; Limit of Detection; MicroRNAs; Molybdenum; Neoplasms; Photons; Quantum Dots; Silicon Dioxide | 2019 |
Redox/NIR dual-responsive MoS
Topics: Animals; Antineoplastic Agents, Phytogenic; Camptothecin; Cell Line, Tumor; Cell Survival; Combined Modality Therapy; Disulfides; Drug Carriers; Drug Liberation; Female; Fluorescent Dyes; Humans; Hyaluronic Acid; Hyperthermia, Induced; Infrared Rays; Mice, Nude; Molybdenum; Nanoparticles; Neoplasm Transplantation; Neoplasms; Oxidation-Reduction; Photochemotherapy | 2019 |
A dual-mode nanoprobe for evaluation of the autophagy level affected by photothermal therapy.
Topics: Aptamers, Nucleotide; Autophagy; Carbocyanines; Down-Regulation; Fluorescent Dyes; Humans; Hyperthermia, Induced; Limit of Detection; MCF-7 Cells; MicroRNAs; Molybdenum; Nanospheres; Neoplasms; Nucleic Acid Hybridization; Oxides; Particle Size; Phototherapy; Spectrometry, Fluorescence; Spectrum Analysis, Raman | 2019 |
Hydrophilic molybdenum oxide nanomaterials with controlled morphology and strong plasmonic absorption for photothermal ablation of cancer cells.
Topics: Absorption; Cell Line, Tumor; Humans; Hydrophobic and Hydrophilic Interactions; Laser Therapy; Molybdenum; Nanostructures; Neoplasms; Oxides; Surface Plasmon Resonance | 2014 |
["Technetium crisis" - causes, possible solutions and consequences for planar scintigraphy and SPECT diagnostics].
Topics: Humans; Molybdenum; Neoplasms; Radioisotopes; Radiopharmaceuticals; Technetium; Tomography, Emission-Computed, Single-Photon | 2014 |
MoS₂ exhibits stronger toxicity with increased exfoliation.
Topics: Antineoplastic Agents; Cell Line, Tumor; Disulfides; Humans; Molybdenum; Nanoparticles; Neoplasms | 2014 |
Two novel compounds of vanadium and molybdenum with carnitine exhibiting potential pharmacological use.
Topics: A549 Cells; Animals; Antineoplastic Agents; Carnitine; Coordination Complexes; Drug Screening Assays, Antitumor; Humans; Mice; Molybdenum; Neoplasms; Vanadium | 2015 |
A Facile One-Pot Synthesis of a Two-Dimensional MoS2 /Bi2S3 Composite Theranostic Nanosystem for Multi-Modality Tumor Imaging and Therapy.
Topics: Animals; Bismuth; Cell Line, Tumor; Contrast Media; Disulfides; Humans; Infrared Rays; Mice; Mice, Nude; Molybdenum; Nanostructures; Neoplasms; Phototherapy; Polyethylene Glycols; Sulfides; Survival Rate; Theranostic Nanomedicine; Tissue Distribution; Tomography, X-Ray Computed | 2015 |
Smart MoS2/Fe3O4 Nanotheranostic for Magnetically Targeted Photothermal Therapy Guided by Magnetic Resonance/Photoacoustic Imaging.
Topics: Animals; Disease Models, Animal; Disulfides; Drug Delivery Systems; Ferric Compounds; HeLa Cells; Hep G2 Cells; Humans; Hyperthermia, Induced; Infrared Rays; Magnetic Resonance Imaging; Male; Mice, Inbred BALB C; Molybdenum; Nanoparticles; Neoplasms; Photoacoustic Techniques; Theranostic Nanomedicine; Treatment Outcome | 2015 |
Graphene-like two-dimensional layered nanomaterials: applications in biosensors and nanomedicine.
Topics: Animals; Biosensing Techniques; Boron Compounds; Cell Line, Tumor; Cell Survival; Disulfides; Drug Carriers; Electrochemical Techniques; Graphite; Humans; Mice; Molybdenum; Nanomedicine; Nanostructures; Neoplasms; Nitriles; Polyethylene Glycols; Tomography, X-Ray Computed | 2015 |
Reusable and dual-potential responses electrogenerated chemiluminescence biosensor for synchronously cytosensing and dynamic cell surface N-glycan evaluation.
Topics: Aptamers, Nucleotide; Biosensing Techniques; Cell Line, Tumor; Cell Membrane; Disulfides; Equipment Design; Humans; Luminescence; Luminescent Agents; Luminescent Measurements; Molybdenum; Nanostructures; Neoplasms; Organometallic Compounds; Phenanthrolines; Polysaccharides | 2015 |
Injectable 2D MoS2 -Integrated Drug Delivering Implant for Highly Efficient NIR-Triggered Synergistic Tumor Hyperthermia.
Topics: Animals; Cell Line; Disulfides; Doxorubicin; Drug Carriers; Hyperthermia, Induced; Infrared Rays; Injections; Lactic Acid; Lasers; Mice; Models, Molecular; Molecular Conformation; Molybdenum; Neoplasms; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Prostheses and Implants | 2015 |
Tetrathiomolybdate inhibits mitochondrial complex IV and mediates degradation of hypoxia-inducible factor-1α in cancer cells.
Topics: Cell Line, Tumor; Cell Respiration; Electron Transport Complex IV; Gene Expression Regulation, Neoplastic; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Molybdenum; Neoplasms; Oxygen; Phosphatidylinositol 3-Kinases; Proteolysis; Proto-Oncogene Proteins c-akt; Signal Transduction | 2015 |
One-pot synthesis of PEGylated plasmonic MoO(3-x) hollow nanospheres for photoacoustic imaging guided chemo-photothermal combinational therapy of cancer.
Topics: Animals; Antineoplastic Agents; Combined Modality Therapy; HeLa Cells; Humans; Hyperthermia, Induced; Mice; Mice, Inbred BALB C; Mice, Nude; Microscopy, Electron, Scanning; Microscopy, Electron, Transmission; Molybdenum; Nanospheres; Neoplasms; Oxides; Phototherapy; Polyethylene Glycols | 2016 |
Aqueous phase preparation of ultrasmall MoSe2 nanodots for efficient photothermal therapy of cancer cells.
Topics: Cell Survival; HeLa Cells; Humans; Infrared Rays; Microscopy, Electron, Transmission; Molybdenum; Nanoparticles; Neoplasms; Photoelectron Spectroscopy; Phototherapy; Polymers; Selenium; Water; X-Ray Diffraction | 2016 |
Single-layer MoS2 nanosheet grafted upconversion nanoparticles for near-infrared fluorescence imaging-guided deep tissue cancer phototherapy.
Topics: Animals; Breast Neoplasms; Cell Line, Tumor; Disulfides; Female; Humans; Infrared Rays; Metal Nanoparticles; Mice; Mice, Nude; Molybdenum; Nanotechnology; Neoplasms; Optical Imaging; Phototherapy; Xenograft Model Antitumor Assays | 2016 |
Enhancing tumor-specific uptake of the anticancer drug cisplatin with a copper chelator.
Topics: Adenosine Triphosphatases; Adjuvants, Pharmaceutic; Adult; Aged; Aged, 80 and over; Animal Structures; Animals; Carboplatin; Cation Transport Proteins; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chelating Agents; Cisplatin; Copper; Copper Transporter 1; Copper-Transporting ATPases; Disease Models, Animal; Disease-Free Survival; DNA Adducts; Female; Gene Expression; Humans; Mice; Mice, Inbred Strains; Middle Aged; Molybdenum; Neoplasms; Neovascularization, Pathologic; Ovarian Neoplasms; Treatment Outcome; Uterine Cervical Neoplasms | 2010 |
Mo(II) complexes: a new family of cytotoxic agents?
Topics: 1-Octanol; Antineoplastic Agents; Breast Neoplasms; Cell Death; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Female; HeLa Cells; Humans; Inhibitory Concentration 50; Molecular Structure; Molybdenum; Neoplasms; Neuroblastoma; Nucleic Acid Conformation; Phenanthrolines; Tetrazolium Salts; Thiazoles; Water | 2010 |
Copper chelation enhances antitumor efficacy and systemic delivery of oncolytic HSV.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Chelating Agents; Combined Modality Therapy; Copper; Cytopathogenic Effect, Viral; Female; Genetic Therapy; Genetic Vectors; Glioma; Humans; Mice; Mice, Nude; Molybdenum; Neoplasms; Oncolytic Virotherapy; Oncolytic Viruses; Simplexvirus; Virus Replication; Xenograft Model Antitumor Assays | 2012 |
The need for selenite and molybdate in the formation of formic dehydrogenase by members of the coli-aerogenes group of bacteria.
Topics: Aldehyde Oxidoreductases; Bacteria; Breast Neoplasms; Enterobacter aerogenes; Escherichia coli; Molybdenum; Neoplasms; Oxidoreductases; Selenious Acid; Selenium; Selenium Compounds | 1954 |
Further observations on the action of preparations of phosphotungstic and phosphomolybdic acids upon cancer.
Topics: Breast Neoplasms; Humans; Male; Molybdenum; Neoplasms; Penile Neoplasms; Penis; Phosphoric Acids; Tungsten | 1954 |
PRELIMINARY PHYSIOLOGICAL STUDIES OF MOLYBDENUM (MO99) IN LIVER SCANNING.
Topics: Humans; Liver; Liver Diseases; Molybdenum; Neoplasms; Radioisotopes; Radionuclide Imaging | 1964 |
TREATMENT OF CANCER OF THE INTESTINAL TRACT WITH A COMPLEX COMPOUND OF PHOSPHOTUNGSTIC PHOSPHOMOLYBDIC ACIDS AND CAFFEINE.
Topics: Antineoplastic Agents; Caffeine; Geriatrics; Humans; Intestinal Neoplasms; Molybdenum; Neoplasms; Phosphoric Acids; Phosphotungstic Acid | 1965 |
Action of preparations of phosphotungstic and phosphomolybdic acids on cancer.
Topics: Genitalia; Genitalia, Male; Humans; Molybdenum; Neoplasms; Phosphoric Acids; Tungsten | 1952 |
Chemotherapy of cancer with phosphotungstic acid-H2O2 and phosphomolybdic acid-H2O2 preparations.
Topics: Humans; Hydrogen Peroxide; Molybdenum; Neoplasms; Phosphoric Acids; Phosphotungstic Acid | 1950 |
[Determination of trace Al in serum of cancer patients by graphite furnace atomic absorption spectrometry using K2Cr2O7 and surfactant as matrix modifier with molybdenate coated tubes].
Topics: Aluminum; Blood Chemical Analysis; Graphite; Humans; Molybdenum; Neoplasms; Potassium Dichromate; Spectrophotometry, Atomic; Surface-Active Agents; Temperature | 1998 |
Molybdenum. Monograph.
Topics: Animals; Coenzymes; Drug Hypersensitivity; Hepatolenticular Degeneration; Humans; Metalloproteins; Molybdenum; Molybdenum Cofactors; Neoplasms; Pteridines; Sulfites | 2006 |
Comparison of lowering copper levels with tetrathiomolybdate and zinc on mouse tumor and doxorubicin models.
Topics: Animals; Antibiotics, Antineoplastic; Ceruloplasmin; Copper; Creatine Kinase; Delayed-Action Preparations; Disease Models, Animal; Doxorubicin; Drug Antagonism; Heart; Instillation, Drug; L-Lactate Dehydrogenase; Male; Mice; Mice, Inbred C57BL; Molybdenum; Neoplasm Transplantation; Neoplasms; Troponin I; Zinc | 2006 |
Molybdenum: an essential trace element.
Topics: Deficiency Diseases; Food Analysis; Humans; Metabolism, Inborn Errors; Molybdenum; Neoplasms; Trace Elements | 1993 |
Cutting copper curbs angiogenesis, studies show.
Topics: Angiogenesis Inhibitors; Brain Neoplasms; Chelating Agents; Clinical Trials as Topic; Combined Modality Therapy; Copper; Glioblastoma; Humans; Molybdenum; Neoplasms; Neovascularization, Pathologic; Penicillamine | 2000 |
Pilot studies on the effects of a phosphomolybdic tungstic acid compound (PTMC) on spontaneous malignant tumours in dogs.
Topics: Animals; Antineoplastic Agents; Dog Diseases; Dogs; Molybdenum; Neoplasms; Organometallic Compounds; Tungsten | 1988 |
An overview of distribution patterns of trace elements in soils and plants.
Topics: Dental Caries; Diet; Environmental Health; Geography; Geological Phenomena; Geology; Goiter; Humans; Iodine; Molybdenum; Morbidity; Neoplasms; Nutrition Disorders; Nutritional Requirements; Plants; Selenium; Soil; Trace Elements; United States | 1972 |
[A new attempt at estimating the activity of the rheumatic process: the influence of urine on the reduction of the molybdates].
Topics: Arthritis, Rheumatoid; Female; Humans; Male; Methods; Molybdenum; Neoplasms; Osteoarthritis; Oxidation-Reduction; Pregnancy; Rheumatic Diseases; Spondylitis, Ankylosing | 1970 |